About Us
Scientific Advisory Board(SAB Team)
Andre Rosowsky, PhD
Dr. Rosowsky received his PhD degree in chemistry from the University of Rochester in 1962. After postodoctoral research in the Department of Chemistry at Harvard University under the direction of Dr. E.J. Corey, he joined the Dana Farber Cancer Institute. Dr. Rosowsky is Associate Professor of Biological Chemistry and Pharmacology at Harvard Medical School. In 1987 he was appointed Associate Professor in the Division of Cancer Pharmacology, now part of the Department of Medical Oncology. He heads a group whose primary goal is the design of novel antifolates as anticancer and antiparasitic drugs.
Andre Rosowsky, PhD
Dr. Rosowsky received his PhD degree in chemistry from the University of Rochester in 1962. After postodoctoral research in the Department of Chemistry at Harvard University under the direction of Dr. E.J. Corey, he joined the Dana Farber Cancer Institute. Dr. Rosowsky is Associate Professor of Biological Chemistry and Pharmacology at Harvard Medical School. In 1987 he was appointed Associate Professor in the Division of Cancer Pharmacology, now part of the Department of Medical Oncology. He heads a group whose primary goal is the design of novel antifolates as anticancer and antiparasitic drugs.
Norton P. Peet, PhD, SAB Chair
Dr. Peet received his PhD degree from the University of Nebraska followed by a postdoctoral appointment at the Massachusetts Institute of Technology. Dr. Peet was founder and CEO of Aurigene Discovery Technologies, V.P. of Discovery Alliances at ArQule, and Head of Medicinal Chemistry and Distinguished Scientist at Aventis. Dr. Peet serves on several editorial boards and has authored 145 technical articles and books. He holds 65 US Patents, which largely cover enzyme inhibitors and receptor ligands for therapeutic targets in the areas of CNS, cardiovascular, metabolic and respiratory diseases, and oncology. Dr. Peet is active in the scientific community; he has organized and chaired several international symposia, he is a member of the IBC USA Board, and locally he has organized and chaired several NESACS Medicinal Chemistry Symposia.
Dr. Krupa S Rajur MD
Advisory Board Chair, Oncology Research
Dr. Rajur received her MD degree in internal medicine from Tufts University school of medicines and completed fellowship in Nephrology from Brown University RI. Currently she is serving as a nephrologist at Southern New Hampshire Medical Center in Nashua and Dartmouth Hitchcock medical center, Manchester NH.
 
News
  CreaGen Inc. makes into the 2018 list of major players in CRO industry
https://www.businesswire.com/news/home/20180412005808/en/Outsourcing-Drug-Discovery-Contract-Research-Organization-CRO https://themobileherald.com/contract-research-organization-market-industry-growth-and-forecast-analysis-report-till-2024/24870/ https://www.businesswire.com/news/home/20180412005808/en/Outsourcing-Drug-Discovery-Contract-Research-Organization-CRO   more...
 
 
Home  |  About Us  |  Services  |  Products  |  R&D  |  News  |  Careers  |  Contact us Copyright © 2013 CreaGen Biosciences Inc. All rights reserved.